Zhong Yang

Person

Middletown, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 10,221,129
- Issue date Mar 5, 2019
- ViiV Healthcare UK (No. 5) Limited
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 10,035,760
- Issue date Jul 31, 2018
- ViiV Healthcare UK (No. 5) Limited
- Annapurna Pendri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 9,855,230
- Issue date Jan 2, 2018
- ViiV Healthcare UK (No. 5) Limited
- Makonen Belema
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,776,981
- Issue date Oct 3, 2017
- Bristol-Myers Squibb Company
- Rico Lavoie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,561,212
- Issue date Feb 7, 2017
- Bristol-Myers Squibb Company
- Jeffrey Lee Romine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors
- Patent number 8,431,568
- Issue date Apr 30, 2013
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 8,377,980
- Issue date Feb 19, 2013
- Bristol-Myers Squibb Company
- Makonen Belema
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 8,143,244
- Issue date Mar 27, 2012
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhib...
- Patent number 8,138,171
- Issue date Mar 20, 2012
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of Hepatitis C
- Patent number 8,129,367
- Issue date Mar 6, 2012
- Bristol-Myers Squibb Company
- Piyasena Hewawasam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of Hepatitis C
- Patent number 8,124,601
- Issue date Feb 28, 2012
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors
- Patent number 8,119,628
- Issue date Feb 21, 2012
- Bristol-Myers Squibb Company
- Zhong Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diazaindole-dicarbonyl-piperazinyl antiviral agents
- Patent number 7,902,204
- Issue date Mar 8, 2011
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of Hepatitis C
- Patent number 7,538,102
- Issue date May 26, 2009
- Bristol-Myers Squibb Company
- Kap-Sun Yeung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,521,444
- Issue date Apr 21, 2009
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclo 4.4.0 antiviral derivatives
- Patent number 7,037,913
- Issue date May 2, 2006
- Bristol-Myers Squibb Company
- Tao Wang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20180086697
- Publication date Mar 29, 2018
- John A. BENDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20180072997
- Publication date Mar 15, 2018
- ViiV HEATHCARE UK (NO.5) LIMITED
- John A. BENDER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HEPATITIS C VIRUS INHIBITOR
- Publication number 20170355689
- Publication date Dec 14, 2017
- Bristol-Myers Squibb Company
- Rico Lavoie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20170304239
- Publication date Oct 26, 2017
- VIIV HEALTHCARE UK (NO.5) LIMITED
- Makonen BELEMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEPATITIS C VIRUS INHIBITORS
- Publication number 20160338999
- Publication date Nov 24, 2016
- Bristol-Myers Squibb Company
- Jeffrey Lee Romine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV...
- Publication number 20160311806
- Publication date Oct 27, 2016
- Bristol-Myers Squibb Company
- John A. Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
- Publication number 20160257645
- Publication date Sep 8, 2016
- Bristol-Myers Squibb Company
- Annapurna Pendri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20150322048
- Publication date Nov 12, 2015
- Bristol-Myers Squibb Company
- Rico Lavoie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEPATITIS C VIRUS INHIBITORS
- Publication number 20150252028
- Publication date Sep 10, 2015
- BRISTOL-MYERS SQUIBB COMPANY
- Jeffrey Lee Romine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20150197499
- Publication date Jul 16, 2015
- Bristol-Myers Squibb Company
- Rico Lavoie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20130115193
- Publication date May 9, 2013
- Bristol-Myers Squibb Company
- Rico Lavoie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20120115847
- Publication date May 10, 2012
- Bristol -Myers Squibb Company
- Piyasena Hewawasam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20110286961
- Publication date Nov 24, 2011
- Bristol -Myers Squibb Company
- Makonen Belema
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20110274648
- Publication date Nov 10, 2011
- Bristol -Myers Squibb Company
- Rico Lavoie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrrolidine Fused Indolobenzadiazepine HCV NS5B Inhibitors
- Publication number 20110020276
- Publication date Jan 27, 2011
- Bristol -Myers Squibb Company
- Zhong Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Dioxolane and Dioxolanone Fused Indolobenzadiazepine HCV NS5B Inhib...
- Publication number 20110020277
- Publication date Jan 27, 2011
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aromatic Heterocyclic Fused Indolobenzadiazepine HCV NS5B Inhibitors
- Publication number 20110014154
- Publication date Jan 20, 2011
- Bristol -Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20100216774
- Publication date Aug 26, 2010
- Bristol -Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090130056
- Publication date May 21, 2009
- Bristol -Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090130057
- Publication date May 21, 2009
- Bristol -Myers Squibb Company
- Piyasena Hewawasam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20080226590
- Publication date Sep 18, 2008
- Bristol -Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20080226592
- Publication date Sep 18, 2008
- Bristol -Myers Squibb Company
- Kap-Sun Yeung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAZAINDOLE-DICARBONYL-PIPERAZINYL ANTIVIRAL AGENTS
- Publication number 20080125439
- Publication date May 29, 2008
- Bristol -Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diazaindole-dicarbonyl-piperazinyl antiviral agents
- Publication number 20050124623
- Publication date Jun 9, 2005
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclo 4.4.0 antiviral derivatives
- Publication number 20040009985
- Publication date Jan 15, 2004
- Tao Wang
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Inhibitors of human immunodeficiency virus replication

Inhibitors of human immunodeficiency virus replication

Inhibitors of human immunodeficiency virus replication

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors

Hepatitis C virus inhibitors

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhib...

Compounds for the treatment of Hepatitis C

Compounds for the treatment of Hepatitis C

Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors

Diazaindole-dicarbonyl-piperazinyl antiviral agents

Compounds for the treatment of Hepatitis C

Compounds for the treatment of hepatitis C

Bicyclo 4.4.0 antiviral derivatives

Patents Applicationslast 30 patents

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

HEPATITIS C VIRUS INHIBITOR

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

HEPATITIS C VIRUS INHIBITORS

4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV...

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Hepatitis C Virus Inhibitors

HEPATITIS C VIRUS INHIBITORS

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors

Compounds for the Treatment of Hepatitis C

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors

Pyrrolidine Fused Indolobenzadiazepine HCV NS5B Inhibitors

Dioxolane and Dioxolanone Fused Indolobenzadiazepine HCV NS5B Inhib...

Aromatic Heterocyclic Fused Indolobenzadiazepine HCV NS5B Inhibitors

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

DIAZAINDOLE-DICARBONYL-PIPERAZINYL ANTIVIRAL AGENTS

Diazaindole-dicarbonyl-piperazinyl antiviral agents

Bicyclo 4.4.0 antiviral derivatives